Microstructural abnormalities in callosal fibers and their relationship with cognitive function in schizophrenia: A tract-specific analysis study.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
08 2019
Historique:
received: 25 09 2018
revised: 14 05 2019
accepted: 14 06 2019
pubmed: 10 7 2019
medline: 2 5 2020
entrez: 9 7 2019
Statut: ppublish

Résumé

The corpus callosum serves the essential role of relaying cognitive information between the homologous regions in the left and the right hemispheres of the brain. Cognitive impairment is a core dysfunction of schizophrenia, but much of its pathophysiology is unknown. The aim of this study was to elucidate the association between microstructural abnormalities of the corpus callosum and cognitive dysfunction in schizophrenia. We examined stepwise multiple regression analysis to investigate the relationship of the fractional anisotropy (FA) of callosal fibers in each segment with z-scores of each brief assessment of cognition in schizophrenia subtest and cognitive composite score in all subjects (19 patients with schizophrenia [SZ group] and 19 healthy controls [HC group]). Callosal fibers were separated into seven segments based on their cortical projection using tract-specific analysis of diffusion tensor imaging. The FA of callosal fibers in the temporal segment was significantly associated with z-scores of token motor test, Tower of London test, and the composite score. In the SZ group, the FA of callosal fibers in the temporal segment was significantly associated with the z-score of the Tower of London test. In addition, the FA of callosal fibers in temporal segment showed significant negative association with the positive and negative syndrome scale negative score in the SZ group. Compared to the HC group, the FA in temporal segment was significantly decreased in the SZ group. Our results suggest that microstructural abnormalities in the callosal white matter fibers connecting bilateral temporal lobe cortices contribute to poor executive function and severe negative symptom in patients with schizophrenia.

Identifiants

pubmed: 31283112
doi: 10.1002/brb3.1357
pmc: PMC6710197
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e01357

Informations de copyright

© 2019 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.

Références

Biol Psychiatry. 2008 Mar 1;63(5):519-23
pubmed: 17662964
Schizophr Res. 2010 May;118(1-3):34-40
pubmed: 19854622
Psychiatry Res. 2013 Jun 30;212(3):201-7
pubmed: 23146248
Neuroimage. 2007 Jul 1;36(3):630-44
pubmed: 17481925
Front Psychiatry. 2013 Jun 24;4:35
pubmed: 23805107
J Psychiatr Res. 2011 Mar;45(3):369-77
pubmed: 20708198
Brain Cogn. 2004 Dec;56(3):286-92
pubmed: 15522766
Psychiatry Res. 2015 Mar 30;231(3):252-61
pubmed: 25649975
Neuroimage. 2008 Feb 15;39(4):1522-32
pubmed: 18096406
Neuropsychopharmacology. 2008 Apr;33(5):976-84
pubmed: 17581532
Neuroimage. 2010 Jan 1;49(1):199-204
pubmed: 19619664
Schizophr Res. 2010 Dec;124(1-3):169-75
pubmed: 20800998
J Psychiatry Neurosci. 2011 Mar;36(2):120-5
pubmed: 21138657
Schizophr Res. 2015 Jan;161(1):19-28
pubmed: 24893909
Neuropsychologia. 2003;41(12):1668-82
pubmed: 12887991
Biol Psychiatry. 2010 Jul 1;68(1):70-7
pubmed: 20494336
Am J Psychiatry. 2002 May;159(5):813-20
pubmed: 11986136
Neuroimage Clin. 2016 May 03;12:970-975
pubmed: 27995063
Psychiatry Res. 2009 Oct 30;174(1):9-16
pubmed: 19767179
Br Med Bull. 2003;65:49-59
pubmed: 12697616
Early Interv Psychiatry. 2018 Aug;12(4):660-668
pubmed: 27621217
Mol Psychiatry. 2010 Aug;15(8):823-30
pubmed: 20065955
AJNR Am J Neuroradiol. 2015 Mar;36(3):448-53
pubmed: 25339653
Neuropsychology. 2004 Oct;18(4):629-637
pubmed: 15506830
Psychol Med. 2011 Aug;41(8):1709-19
pubmed: 20809999
J Affect Disord. 2015 Mar 15;174:542-8
pubmed: 25556672
Front Hum Neurosci. 2014 Aug 25;8:653
pubmed: 25202257
Schizophr Res. 2009 May;110(1-3):119-26
pubmed: 19328656
Schizophr Res. 2012 Jul;138(2-3):136-42
pubmed: 22475381
Neuroimage. 2008 Feb 1;39(3):949-55
pubmed: 17988894
Neuroimage. 2010 Aug 1;52(1):20-31
pubmed: 20362683
Schizophr Res. 2014 Oct;159(1):31-5
pubmed: 25176348
J Magn Reson B. 1996 Jun;111(3):209-19
pubmed: 8661285
Neurosurg Clin N Am. 2011 Apr;22(2):185-96, viii
pubmed: 21435570
J Clin Psychiatry. 2016 Feb;77(2):205-11
pubmed: 26761708
Psychiatry Clin Neurosci. 2017 May;71(5):301-308
pubmed: 27873453
Schizophr Bull. 2015 Jan;41(1):300-10
pubmed: 24962608
PLoS One. 2012;7(8):e39804
pubmed: 22870191
Sci Rep. 2017 Jun 7;7(1):2978
pubmed: 28592900
Neuropsychologia. 2006;44(12):2259-69
pubmed: 16797612
Clin Neuroradiol. 2016 Jun;26(2):199-208
pubmed: 25283182
Neurosci Biobehav Rev. 2006;30(6):762-74
pubmed: 16890990
Psychiatry Res. 2015 Mar 30;231(3):244-51
pubmed: 25637358
Psychiatry Res. 2014 Aug 30;223(2):148-56
pubmed: 24909602
Psychiatry Res. 2007 Nov 15;156(2):93-104
pubmed: 17884391
Schizophr Res. 2010 Feb;116(2-3):196-203
pubmed: 19854618
Mol Psychiatry. 2018 May;23(5):1261-1269
pubmed: 29038599
Neuroimage. 2005 May 15;26(1):195-205
pubmed: 15862219
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8
pubmed: 15976020
Neuroimage. 2012 Jan 16;59(2):926-34
pubmed: 21964509
Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:5494-7
pubmed: 19163961
Psychol Med. 2013 Oct;43(10):2047-56
pubmed: 23237024
Biol Psychiatry. 2003 Dec 1;54(11):1171-80
pubmed: 14643084
J Neuroimaging. 2014 Mar-Apr;24(2):101-10
pubmed: 23317110
Schizophr Res. 2009 Mar;108(1-3):41-8
pubmed: 19103476
Curr Opin Psychiatry. 2014 May;27(3):179-84
pubmed: 24613986
Psychiatry Clin Neurosci. 2007 Dec;61(6):602-9
pubmed: 18081619
Schizophr Res. 2010 Jun;119(1-3):52-60
pubmed: 20056394
Br J Psychiatry. 2009 Oct;195(4):346-53
pubmed: 19794204
Psychiatry Clin Neurosci. 2017 May;71(5):318-327
pubmed: 28294477
Am J Psychiatry. 2003 Mar;160(3):572-4
pubmed: 12611842
Front Hum Neurosci. 2014 Dec 22;8:1010
pubmed: 25566030
Acta Psychiatr Scand Suppl. 1999;395:68-79
pubmed: 10225335
Psychiatry Clin Neurosci. 2012 Feb;66(1):34-43
pubmed: 22250608
Psychiatry Res. 2006 Apr 30;146(3):223-9
pubmed: 16527464
Psychiatry Res. 2012 Jun 30;202(3):233-8
pubmed: 22819228
Schizophr Res. 2008 Jan;98(1-3):157-62
pubmed: 18031994
Schizophr Res Cogn. 2017 May 18;9:8-12
pubmed: 28740828
BMC Psychiatry. 2014 Apr 02;14:99
pubmed: 24693962
Eur Arch Psychiatry Clin Neurosci. 2005 Oct;255(5):313-8
pubmed: 15647957
Schizophr Res. 2013 Feb;143(2-3):231-8
pubmed: 23290268
Psychiatry Res. 2014 Jan 30;221(1):58-62
pubmed: 24300086
Schizophr Res. 2015 Mar;162(1-3):22-8
pubmed: 25660467
PLoS One. 2016 Aug 18;11(8):e0161406
pubmed: 27536773
Psychol Med. 2015 Jan;45(1):109-20
pubmed: 25066842
Neurosci Res. 2010 Apr;66(4):340-4
pubmed: 20025912
Psychiatry Clin Neurosci. 2017 Nov;71(11):769-779
pubmed: 28657683
Schizophr Res. 2011 Aug;130(1-3):78-85
pubmed: 21561738
Psychiatry Res. 2010 May 30;182(2):123-33
pubmed: 20456929
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:117-23
pubmed: 24099786
Brain Behav. 2019 Aug;9(8):e01357
pubmed: 31283112
J Neurosci. 2007 Oct 31;27(44):11869-76
pubmed: 17978027
Biol Psychiatry. 2008 Mar 1;63(5):512-8
pubmed: 17720147
Psychol Med. 2008 Jun;38(6):877-85
pubmed: 17949516
Schizophr Res. 2013 Jan;143(1):172-8
pubmed: 23148898
Schizophr Res. 2013 May;146(1-3):238-43
pubmed: 23523695
J Physiol Paris. 2006 Jun;99(4-6):308-17
pubmed: 16750617
Behav Brain Res. 2013 Sep 1;252:157-63
pubmed: 23747517
Radiographics. 2005 Jan-Feb;25(1):53-65; discussion 66-8
pubmed: 15653586
Schizophr Res. 2009 Mar;108(1-3):3-10
pubmed: 19128945
NMR Biomed. 1995 Nov-Dec;8(7-8):333-44
pubmed: 8739270
Acta Psychiatr Scand. 2013 Oct;128(4):261-70
pubmed: 23216145
Exp Ther Med. 2016 Sep;12(3):1450-1454
pubmed: 27588066
Biol Psychiatry. 2011 Oct 1;70(7):672-9
pubmed: 21784414
Neurosci Res. 2016 Jan;102:29-38
pubmed: 26235681
Biol Psychiatry. 2004 Jun 15;55(12):1138-45
pubmed: 15184032
Schizophr Res Cogn. 2014 Mar;1(1):e1-e9
pubmed: 25254156
Schizophr Res. 2008 Dec;106(2-3):125-31
pubmed: 18829262
Psychiatry Clin Neurosci. 2015 Aug;69(8):440-7
pubmed: 25601291

Auteurs

Yuji Ohoshi (Y)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Shun Takahashi (S)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Shinichi Yamada (S)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Takuya Ishida (T)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Kumi Tsuda (K)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Tomikimi Tsuji (T)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Masaki Terada (M)

Wakayama-Minami Radiology Clinic, Wakayama, Japan.

Kazuhiro Shinosaki (K)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.
Asakayama General Hospital, Osaka, Japan.

Satoshi Ukai (S)

Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH